Synthes Reports 2Q Sales of $992M, 11.2% Increase

Synthes reported consolidated sales of $992 million during the second quarter of 2011, an 11.2 percent increase over the same period last year, according to a company news release.

Advertisement

The company’s comprehensive pedicle screw system, which was launched during the fourth quarter of 2010, has continued to expand and exceed expectations in the United States market. Despite the weak economy, the company experienced growth in the North American and European trauma markets.

The sales growth rate declined in the rest of the world, due to a one time effect of the Middle Eastern tender order delivery, according to the report.

Read the financial report for Synthes.

Related Articles on Device Companies:

InVivo Therapeutics Reports Increased Net Loss During Q2

Knee Business Big for Smith & Nephew’s 9% Revenue Increase in 2Q

TranS1 Revenues Continue to Slide in 2Q With 26% Decrease

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.